Norfloxacin nicotinate pharmacokinetics in unweaned and weaned calves

被引:23
作者
Gips, M
Soback, S
机构
[1] MINIST AGR,KIMRON VET INST,NATL RESIDUE CONTROL LAB,IL-50250 BET DAGAN,ISRAEL
[2] HEBREW UNIV JERUSALEM,FAC MED,SCH PHARM,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1111/j.1365-2885.1996.tb00025.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of norfloxacin nicotinate were investigated in unweaned and weaned calves. Following intravenous administration of 7.5 and 15 mg/kg (calculated as norfloxacin base) the clearance values were 8.5+/-2.0 or 7.7+/-1.2 ml/min . kg (unweaned calves) and 11.7+/-3.2 or 16.1+/-3.3 mL/min . kg (weaned calves). Norfloxacin mean residence time and volume of distribution values were 211+/-33 or 227+/-41 min (unweaned calves) and 185+/-79 or 128+/-18 minutes (weaned calves), and 1.8+/-0.3 or 1.7+/-0.1 L/kg (unweaned calves) and 2.0+/-0.7 or 2.1+/-0.7 L/kg (weaned calves) following administration of the lower and higher dose, respectively, These results indicated that norfloxacin pharmacokinetics were similar at a dose range of 7.5-15 mg/kg. However, a significant difference was observed in clearance, mean residence time and the half-life values between the unweaned and weaned calves. The only major pharmacokinetic parameter which did not show a significant difference between the investigated groups was the volume of distribution. The pharmacokinetic differences between the non-ruminating (unweaned) and ruminating (weaned) animals seemed to result from changes in drug clearance. The absorption rate after intramuscular administration appeared to change as a result of dose increase. Norfloxacin bioavailability following intramuscular administration ranged from 73 to 106%. The results suggested that larger injection volumes may reduce the extent of absorption.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 15 条
[1]  
BARNETT A, 1961, REACTIONS RUMEN, P6
[2]  
Barry A.L, 1990, NEW GENERATION QUINO, P79
[3]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[4]  
DORFLINGER T, 1986, KLIN EXPT UROLOGIE, V11, P35
[5]  
Gibaldi M., 1982, PHARMACOKINETICS, P409
[6]   PHARMACOKINETIC STUDIES OF NORFLOXACIN IN LABORATORY-ANIMALS [J].
GILFILLAN, EC ;
PELAK, BA ;
BLAND, JA ;
MALATESTA, PF ;
GADEBUSCH, HH .
CHEMOTHERAPY, 1984, 30 (05) :288-296
[7]   NORFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
HOLMES, B ;
BROGDEN, RN ;
RICHARDS, DM .
DRUGS, 1985, 30 (06) :482-513
[8]   INPUT-OUTPUT ANALYSIS FOR TOTAL INPUT RATE AND TOTAL TRACED MASS OF BODY CHOLESTEROL IN MAN [J].
PERL, W ;
SAMUEL, P .
CIRCULATION RESEARCH, 1969, 25 (02) :191-&
[9]  
PHILLIS J, 1976, VET PHYSL, P416
[10]   THE APPLICATION OF STATISTICAL MOMENT THEORY TO THE EVALUATION OF INVIVO DISSOLUTION TIME AND ABSORPTION TIME [J].
RIEGELMAN, S ;
COLLIER, P .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :509-534